Related Experiment Video
Updated: Dec 22, 2025

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
Published on: September 26, 2018
Cardiovascular manifestations and treatment considerations in COVID-19
Yu Kang1, Tiffany Chen1, David Mui2
1Cardiovascular Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
Insights
COVID-19 significantly increases the risk of severe illness and death, particularly in patients with pre-existing cardiovascular conditions. The virus also directly causes various cardiac complications, necessitating specific management strategies.
Area of Science:
- Cardiology
- Infectious Diseases
- Public Health
Background:
- COVID-19 (coronavirus disease 2019) pandemic has led to widespread global health challenges.
- Pre-existing comorbidities like hypertension, diabetes, and cardiovascular disease (CVD) are linked to increased COVID-19 severity and mortality.
- COVID-19 is recognized to precipitate acute cardiovascular complications, mirroring effects seen in other viral respiratory illnesses.
Purpose of the Study:
- To outline the significant cardiovascular complications associated with COVID-19.
- To highlight the similarities between COVID-19 and other viral infections regarding cardiovascular impact.
- To discuss essential cardiovascular considerations in the supportive management of COVID-19 patients.
Main Methods:
- Review of current literature on COVID-19 and cardiovascular complications.
- Analysis of clinical data linking comorbidities to COVID-19 outcomes.
- Examination of therapeutic strategies for managing cardiac issues in COVID-19.
Main Results:
- COVID-19 is associated with increased severity and fatality in patients with hypertension, diabetes, and CVD.
- Reported cardiovascular complications include acute myocardial injury, myocarditis, stress-cardiomyopathy, arrhythmias, cardiogenic shock, and cardiac arrest.
- Cardiovascular interactions of COVID-19 share similarities with SARS, MERS, and influenza.
Conclusions:
- COVID-19 poses a substantial threat to cardiovascular health, exacerbating existing conditions and causing new cardiac problems.
- Management requires careful consideration of anticoagulation, renin-angiotensin-aldosterone system inhibitors, arrhythmia monitoring, and circulatory support.
- Understanding these cardiovascular interactions is crucial for optimizing patient care during the pandemic.
Abstract:
Since its recognition in December 2019, covid-19 has rapidly spread globally causing a pandemic. Pre-existing comorbidities such as hypertension, diabetes, and cardiovascular disease are associated with a greater severity and higher fatality rate of covid-19. Furthermore, COVID-19 contributes to cardiovascular complications, including acute myocardial injury as a result of acute coronary syndrome, myocarditis, stress-cardiomyopathy, arrhythmias, cardiogenic shock, and cardiac arrest. The cardiovascular interactions of COVID-19 have similarities to that of severe acute respiratory syndrome, Middle East respiratory syndrome and influenza. Specific cardiovascular considerations are also necessary in supportive treatment with anticoagulation, the continued use of renin-angiotensin-aldosterone system inhibitors, arrhythmia monitoring, immunosuppression or modulation, and mechanical circulatory support.
Related Concept Videos
Coronary Artery Disease III: Clinical Manifestations
Myocarditis III: Medical Management
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Cardiomyopathy VI: Nursing Management
Myocarditis IV: Nursing Management
Cardiomyopathy V: Interprofessional Care

